Aprofol AG kombiniert Fakten über die Eigenschaften der verschiedenen Folatformen mit neuesten wissenschaftlichen Erkenntnissen.
| Website | http://aprofol.com |
| Revenue | $4 million |
| Employees | 7 (3 on RocketReach) |
| Founded | 2013 |
| Address | 18 Brülisauerstrasse, Appenzell, Appenzell Innerrhoden 9050, CH |
| Phone | +41 71 787 06 06 |
| Industry | Pharmaceutical Manufacturing, Manufacturing General, Manufacturing |
| Keywords | Bioavailability, Nutritional Science, Scientific Research, Biochemistry, Health Research, Scientific Publications, Cellular Function, Health Supplements, Food Science, Nutrient Analysis, Health And Wellness |
| Competitors | Novartis, Pfizer, GSK, Amgen, Baxter International Inc., Merck Group, Sandoz, Fresenius Kabi, Hikma Pharmaceuticals, BRAUN CANADA LTD/LTEE +40 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies |
Looking for a particular Aprofol AG employee's phone or email?
The Aprofol AG annual revenue was $4 million in 2026.
Gerd Wiesler is the CEO of Aprofol AG.
3 people are employed at Aprofol AG.
Aprofol AG is based in Appenzell, Appenzell Innerrhoden.
The NAICS codes for Aprofol AG are [32, 32541, 3254, 325].
The SIC codes for Aprofol AG are [283, 28].